tiprankstipranks
aTyr Pharma (DE:471A)
FRANKFURT:471A
Holding DE:471A?
Track your performance easily

aTyr Pharma (471A) Financial Statements

3 Followers

aTyr Pharma Financial Overview

aTyr Pharma's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; aTyr Pharma is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is €-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 235.00K-$ 353.00K
Gross Profit--$ 235.00K-$ 353.00K
EBIT$ -17.26M$ -16.31M$ -16.64M$ -16.93M$ -12.62M
EBITDA$ -16.87M$ -15.11M$ -15.87M$ -14.24M$ -11.62M
Net Income Common Stockholders$ -17.26M$ -16.31M$ -15.49M$ -14.76M$ -11.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.99M$ 78.48M$ 84.50M$ 98.17M$ 102.13M
Total Assets$ 91.62M$ 105.94M$ 113.25M$ 120.65M$ 125.07M
Total Debt$ 13.57M$ 13.85M$ 14.13M$ 15.10M$ 15.22M
Net Debt$ -52.42M$ -64.63M$ -70.37M$ -83.07M$ -86.91M
Total Liabilities$ 26.48M$ 24.52M$ 28.97M$ 30.18M$ 26.87M
Stockholders Equity$ 65.33M$ 81.61M$ 84.48M$ 90.68M$ 98.39M
Cash Flow-
Free Cash Flow$ -13.17M$ -20.46M$ -22.40M$ -11.08M$ -10.12M
Operating Cash Flow$ -13.16M$ -20.45M$ -22.38M$ -11.06M$ -9.56M
Investing Cash Flow$ 17.95M$ 6.73M$ -1.36M$ 17.82M$ 4.38M
Financing Cash Flow$ -105.00K$ 13.40M$ 7.73M$ 6.03M$ 2.68M
Currency in USD

aTyr Pharma Earnings and Revenue History

aTyr Pharma Debt to Assets

aTyr Pharma Cash Flow

aTyr Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis